Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 27 | $12,897,789 |
Sells | 235 | $31,547,064 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
18 Apr 2024 17:12 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 17 Apr 2024 | Sale | 23,124 | 7.583 | 175,349 | D |
18 Apr 2024 17:12 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 16 Apr 2024 | Sale | 25,000 | 7.6663 | 191,658 | D |
18 Apr 2024 17:12 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 16 Apr 2024 | Sale | 11,447 | 7.6636 | 87,725 | D |
05 Apr 2024 17:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Apr 2024 | Sale | 25,000 | 9.02 | 225,500 | I |
05 Apr 2024 17:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Apr 2024 | Sale | 25,000 | 8.84 | 221,000 | I |
05 Apr 2024 17:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Apr 2024 | Sale | 40,000 | 9.02 | 360,800 | D |
05 Apr 2024 17:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Apr 2024 | Sale | 40,000 | 8.84 | 353,600 | D |
03 Apr 2024 17:42 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 02 Apr 2024 | Sale | 11,447 | 8.8182 | 100,942 | D |
01 Apr 2024 18:40 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 28 Mar 2024 | Sale | 25,000 | 10.1 | 252,500 | I |
01 Apr 2024 18:40 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 28 Mar 2024 | Sale | 40,000 | 10.1 | 404,000 | D |
25 Mar 2024 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 21 Mar 2024 | Sale | 610 | 11.3361 | 6,915 | D |
25 Mar 2024 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 21 Mar 2024 | Sale | 7,390 | 10.6989 | 79,065 | D |
21 Mar 2024 17:38 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 19 Mar 2024 | Sale | 20,054 | 10.792 | 216,423 | D |
28 Aug 2023 18:04 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 24 Aug 2023 | Sale | 63 | 9.4532 | 596 | D |
28 Aug 2023 18:04 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 24 Aug 2023 | Sale | 2,937 | 8.639 | 25,373 | D |
24 Aug 2023 17:51 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 22 Aug 2023 | Sale | 8,885 | 8.9118 | 79,181 | D |
17 Aug 2023 18:35 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 16 Aug 2023 | Sale | 25,000 | 8.9007 | 222,518 | D |
17 Aug 2023 18:35 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 15 Aug 2023 | Sale | 25,000 | 9.2717 | 231,792 | D |
17 Aug 2023 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Aug 2023 | Sale | 18,000 | 9.25 | 166,500 | D |
10 Aug 2023 17:33 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 08 Aug 2023 | Sale | 3,272 | 11.7468 | 38,436 | D |
10 Aug 2023 17:33 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 08 Aug 2023 | Sale | 14,498 | 11.0255 | 159,848 | D |
04 Aug 2023 17:51 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Aug 2023 | Sale | 4,060 | 13.3631 | 54,254 | D |
04 Aug 2023 17:51 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Aug 2023 | Sale | 60,955 | 13.0171 | 793,457 | D |
28 Jul 2023 17:50 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 27 Jul 2023 | Sale | 4,373 | 14.0461 | 61,424 | D |
28 Jul 2023 17:50 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 27 Jul 2023 | Sale | 3,627 | 13.1155 | 47,570 | D |
27 Jul 2023 18:30 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 25 Jul 2023 | Sale | 18,719 | 14.6089 | 273,464 | D |
27 Jul 2023 18:31 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 26 Jul 2023 | Sale | 20,000 | 14.41 | 288,200 | D |
27 Jul 2023 18:31 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 25 Jul 2023 | Sale | 20,000 | 14.3 | 286,000 | D |
19 Jul 2023 19:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 19 Jul 2023 | Sale | 9,859 | 15.999 | 157,734 | D |
19 Jul 2023 19:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 19 Jul 2023 | Sale | 13,150 | 15.3626 | 202,018 | D |
19 Jul 2023 19:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 19 Jul 2023 | Sale | 1,991 | 14.3626 | 28,596 | D |
19 Jul 2023 19:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 18 Jul 2023 | Sale | 500 | 14.048 | 7,024 | D |
19 Jul 2023 19:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 18 Jul 2023 | Sale | 24,500 | 13.6236 | 333,778 | D |
19 Jul 2023 19:01 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 18 Jul 2023 | Sale | 30,000 | 13.74 | 412,200 | D |
19 Jul 2023 19:01 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 17 Jul 2023 | Sale | 30,000 | 11.72 | 351,600 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | BURRELL TERRY-ANN | Director | 12 Jul 2023 | Sale | 3,157 | 14.0821 | 44,457 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | BURRELL TERRY-ANN | Director | 13 Jul 2023 | Sale | 8,275 | 12.5852 | 104,143 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | BURRELL TERRY-ANN | Director | 12 Jul 2023 | Sale | 3,195 | 13.1845 | 42,124 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | BURRELL TERRY-ANN | Director | 12 Jul 2023 | Sale | 78,071 | 12.1465 | 948,289 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | BURRELL TERRY-ANN | Director | 12 Jul 2023 | Sale | 24,302 | 11.2501 | 273,400 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 13 | 14.85 | 193 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 63 | 13.7541 | 867 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 127 | 12.3559 | 1,569 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 561 | 11.8245 | 6,634 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 550 | 14.0291 | 7,716 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 236 | 10.8698 | 2,565 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 4,693 | 12.4131 | 58,255 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 10,327 | 11.7442 | 121,282 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 4,430 | 10.8382 | 48,013 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 127 | 14.0601 | 1,786 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 850 | 12.4076 | 10,546 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 2,173 | 11.8005 | 25,642 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 850 | 10.8206 | 9,198 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 17,227 | 14.344 | 247,104 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 3,270 | 12.3873 | 40,506 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 7,898 | 11.7969 | 93,172 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 3,423 | 10.8658 | 37,194 | D |
13 Jul 2023 16:54 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 11 Jul 2023 | Sale | 8,885 | 6.8873 | 61,194 | D |
09 Jun 2023 17:12 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 07 Jun 2023 | Sale | 56,436 | 9.0511 | 510,808 | D |
05 Jun 2023 18:29 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 02 Jun 2023 | Sale | 17,865 | 8.93 | 159,534 | D |
05 Jun 2023 18:29 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 01 Jun 2023 | Sale | 25,000 | 8.58 | 214,500 | D |
02 Jun 2023 18:05 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 31 May 2023 | Sale | 3,000 | 8.6294 | 25,888 | D |
01 Jun 2023 17:41 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 30 May 2023 | Sale | 8,885 | 8.7939 | 78,134 | D |
17 May 2023 18:22 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 16 May 2023 | Sale | 8,885 | 5.0918 | 45,241 | D |
05 May 2023 18:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 May 2023 | Sale | 1,000 | 4.9151 | 4,915 | I |
05 May 2023 18:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 May 2023 | Sale | 20,000 | 4.9018 | 98,036 | I |
05 May 2023 18:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 May 2023 | Sale | 4,000 | 4.9058 | 19,623 | I |
05 May 2023 18:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 May 2023 | Sale | 33,073 | 4.7096 | 155,761 | D |
28 Apr 2023 16:32 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Jan 2022 | Sale A | 18,500 | 7.3875 | 136,669 | D |
20 Apr 2023 17:37 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 18 Apr 2023 | Sale | 8,885 | 5.9347 | 52,730 | D |
07 Apr 2023 17:30 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Apr 2023 | Sale | 40,000 | 6.6418 | 265,672 | D |
07 Apr 2023 17:30 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Apr 2023 | Sale | 13,327 | 6.4559 | 86,038 | D |
06 Apr 2023 17:38 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 04 Apr 2023 | Sale | 8,885 | 6.5269 | 57,992 | D |
23 Mar 2023 17:07 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 21 Mar 2023 | Sale | 8,885 | 7.3994 | 65,744 | D |
10 Mar 2023 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 09 Mar 2023 | Sale | 15,000 | 7.7747 | 116,620 | D |
10 Mar 2023 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 08 Mar 2023 | Sale | 1,000 | 8.0867 | 8,087 | I |
10 Mar 2023 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 08 Mar 2023 | Sale | 20,000 | 8.095 | 161,900 | I |
10 Mar 2023 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 08 Mar 2023 | Sale | 4,000 | 8.0904 | 32,362 | I |
10 Mar 2023 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 08 Mar 2023 | Sale | 70,890 | 8.096 | 573,925 | D |
09 Mar 2023 17:36 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 07 Mar 2023 | Sale | 8,885 | 8.3274 | 73,989 | D |
06 Mar 2023 18:07 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Mar 2023 | Sale | 1,000 | 7.9086 | 7,909 | I |
06 Mar 2023 18:07 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Mar 2023 | Sale | 1,000 | 7.9059 | 7,906 | I |
06 Mar 2023 18:07 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Mar 2023 | Sale | 500 | 7.9041 | 3,952 | I |
06 Mar 2023 18:07 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Mar 2023 | Sale | 18,500 | 7.919 | 146,502 | D |
03 Mar 2023 16:09 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 02 Mar 2023 | Purchase | 66,822 | 7.8171 | 522,354 | I |
02 Mar 2023 16:05 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 01 Mar 2023 | Purchase | 48,867 | 7.9416 | 388,082 | I |
01 Mar 2023 16:06 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 28 Feb 2023 | Purchase | 815 | 7.97 | 6,496 | I |
28 Feb 2023 16:14 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 27 Feb 2023 | Purchase | 52,500 | 7.69 | 403,725 | I |
27 Feb 2023 17:46 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 23 Feb 2023 | Sale | 8,000 | 7.8175 | 62,540 | D |
27 Feb 2023 16:06 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 24 Feb 2023 | Purchase | 109,118 | 7.639 | 833,552 | I |
24 Feb 2023 16:08 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 23 Feb 2023 | Purchase | 51,864 | 7.7856 | 403,792 | I |
23 Feb 2023 17:48 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 21 Feb 2023 | Sale | 8,885 | 7.733 | 68,708 | D |
23 Feb 2023 16:26 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 22 Feb 2023 | Purchase | 50,941 | 7.8329 | 399,016 | I |
22 Feb 2023 16:07 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 21 Feb 2023 | Purchase | 94,418 | 7.7435 | 731,126 | I |
21 Feb 2023 16:07 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 17 Feb 2023 | Purchase | 63,382 | 7.7149 | 488,986 | I |
17 Feb 2023 17:27 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 16 Feb 2023 | Purchase | 42,682 | 7.8966 | 337,043 | I |
17 Feb 2023 17:13 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 16 Feb 2023 | Sale | 1,768 | 8.42 | 14,887 | D |
17 Feb 2023 17:13 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Feb 2023 | Sale | 7,486 | 8.33 | 62,358 | D |
15 Feb 2023 16:06 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 14 Feb 2023 | Purchase | 6,300 | 7.946 | 50,060 | I |
14 Feb 2023 16:10 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 13 Feb 2023 | Purchase | 32,474 | 7.9706 | 258,837 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)